United States · Seed startup

Who invested in InRev

One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Insurtech

Funding summaryUpdated 15 Nov 2026

$3.8Mraised across 1 round since 2025, from 1 source

Latest round
Seed, $3.8MJan 2025
Investors
0
See who backed them

The rounds

  1. Jan 2025
    Seed$3.8M

    No investor was named in the report.

    Source recorded

Funding filed with regulators

InRev filed one raise, $1.0M in all. Filings say how much was sold and to how many investors; they never name the investors.

  1. Jan 2022$1.0M7 investorsequity, otherof $1.2M offeredSEC Form D

Founders and team

From InRev's own website and the SEC filings it signed: 1 founder, 12 on the team.

Jack GenetFounder & CEO
  • Charlie YatesChief Underwriting Officer
  • Nick BenenatiChief Distribution Officer
  • Thomas CurleyChief Technology Officer
  • Lexie RyderHead of Operations
  • Austin SalisburySenior Software Engineer
  • Cepehr AlizadehSenior Data Scientist
  • Connor PheePrincipal Software Engineer
  • Laura CobbOperations Lead
  • Richard GomezStaff Software Engineer
  • Riley MorelandSenior Software Engineer
  • Sean PatrickSenior Software Engineer
  • John (""Jack"") GenetExecutive Officer, Directori

On the board, as filediJoseph Lee ArnoldSydney Lee Farr

Quick answers about InRev

How much has InRev raised?

InRev has raised $3.8M across 1 round since 2025.

When did InRev last raise?

InRev's most recent round was a Seed of $3.8M in Jan 2025.

What was InRev's biggest round?

Its most recent round, $3.8M in Jan 2025, is also its largest on record.

What stage is InRev at?

InRev's latest named round is a Seed, in Jan 2025.

Where is InRev based?

InRev is based in the United States.

Companies like InRev

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.